^
Association details:
Biomarker:No biomarker
Cancer:Gastroesophageal Junction Adenocarcinoma
Drug:capecitabine (Thymidylate synthase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
12/23/2020
Excerpt:
Gastroesophageal Junction Adenocarcinoma: Principles of systemic therapy…Other recommended regimens…Fluoropyrimidine (fluorouracil or capecitabine)